K. Yonekura, “Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma”, Acta Derm Venereol, vol. 96, no. 7, pp. 1000–1002, Apr. 2016.